Pub. L. 108-199, div. E, tit. II, sec. 220

Designation of S enator Paul D. Wellstone NIH MDCRC Program.

EnactedYear: 2004Length: 214 wordsOfficial source
Sec. 220. Designation of S enator Paul D. Wellstone NIH MDCRC Program. (a) Findings.—Congress finds the following:(1) On December 18, 2001, Public Law 107–84, otherwise known as the Muscular Dystrophy Community Assistance, Research and Education Amendments of 2001, or the MD CARE Act, was signed into law to provide for research and education with respect to various forms of muscular dystrophy, including Duchenne, Becker, limb girdle, congenital, facioscapulohumeral, myotonic, oculopharyngeal, distal, and EmeryDreifuss muscular dystrophies.(2) In response to the MD CARE Act of 2001, in September 2002, the National Institutes of Health (NIH) announced its intention to establish the Muscular Dystrophy Cooperative Research Centers (MDCRC) program.(3) Senator Paul D. Wellstone was a driving force behind enactment of the MD CARE Act, which led to the establishment of the MDCRC program.(b) Designation.—The NIH Muscular Dystrophy Cooperative Research Centers (MDCRC) program shall be known and designated as the “Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers”, in honor of Senator Paul D. Wellstone who was deceased on October 25, 2002.(c) References.—Any reference in a law, regulation, document, paper, or other record of the United States to the NIH program of Muscular Dystrophy Cooperative Research Centers shall be deemed to be a reference to the “Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers”.118 STAT. 256
Pub. L. 108-199, div. E, tit. II, sec. 220: Designation of S enator Paul D. Wellstone NIH MDCRC Program. | Justis AI